313 related articles for article (PubMed ID: 24554308)
1. Olfactory bulb involvement in neurodegenerative diseases.
Attems J; Walker L; Jellinger KA
Acta Neuropathol; 2014 Apr; 127(4):459-75. PubMed ID: 24554308
[TBL] [Abstract][Full Text] [Related]
2. Olfactory dysfunctions in neurodegenerative disorders.
Ruan Y; Zheng XY; Zhang HL; Zhu W; Zhu J
J Neurosci Res; 2012 Sep; 90(9):1693-700. PubMed ID: 22674288
[TBL] [Abstract][Full Text] [Related]
3. Olfactory tau pathology in Alzheimer disease and mild cognitive impairment.
Attems J; Jellinger KA
Clin Neuropathol; 2006; 25(6):265-71. PubMed ID: 17140156
[TBL] [Abstract][Full Text] [Related]
4. Tau pathology in the olfactory bulb correlates with Braak stage, Lewy body pathology and apolipoprotein epsilon4.
Tsuboi Y; Wszolek ZK; Graff-Radford NR; Cookson N; Dickson DW
Neuropathol Appl Neurobiol; 2003 Oct; 29(5):503-10. PubMed ID: 14507342
[TBL] [Abstract][Full Text] [Related]
5. Alpha-synuclein pathology in the olfactory pathways of dementia patients.
Hubbard PS; Esiri MM; Reading M; McShane R; Nagy Z
J Anat; 2007 Jul; 211(1):117-24. PubMed ID: 17553102
[TBL] [Abstract][Full Text] [Related]
6. The olfactory bulb as the entry site for prion-like propagation in neurodegenerative diseases.
Rey NL; Wesson DW; Brundin P
Neurobiol Dis; 2018 Jan; 109(Pt B):226-248. PubMed ID: 28011307
[TBL] [Abstract][Full Text] [Related]
7. Alzheimer's disease and alpha-synuclein pathology in the olfactory bulbs of infants, children, teens and adults ≤ 40 years in Metropolitan Mexico City. APOE4 carriers at higher risk of suicide accelerate their olfactory bulb pathology.
Calderón-Garcidueñas L; González-Maciel A; Reynoso-Robles R; Kulesza RJ; Mukherjee PS; Torres-Jardón R; Rönkkö T; Doty RL
Environ Res; 2018 Oct; 166():348-362. PubMed ID: 29935448
[TBL] [Abstract][Full Text] [Related]
8. Olfactory involvement in aging and Alzheimer's disease: an autopsy study.
Attems J; Lintner F; Jellinger KA
J Alzheimers Dis; 2005 Apr; 7(2):149-57; discussion 173-80. PubMed ID: 15851853
[TBL] [Abstract][Full Text] [Related]
9. Co-localization of tau and alpha-synuclein in the olfactory bulb in Alzheimer's disease with amygdala Lewy bodies.
Fujishiro H; Tsuboi Y; Lin WL; Uchikado H; Dickson DW
Acta Neuropathol; 2008 Jul; 116(1):17-24. PubMed ID: 18446351
[TBL] [Abstract][Full Text] [Related]
10. Olfactory system pathology as a model of Lewy neurodegenerative disease.
Duda JE
J Neurol Sci; 2010 Feb; 289(1-2):49-54. PubMed ID: 19783257
[TBL] [Abstract][Full Text] [Related]
11. An early dysregulation of FAK and MEK/ERK signaling pathways precedes the β-amyloid deposition in the olfactory bulb of APP/PS1 mouse model of Alzheimer's disease.
Lachén-Montes M; González-Morales A; de Morentin XM; Pérez-Valderrama E; Ausín K; Zelaya MV; Serna A; Aso E; Ferrer I; Fernández-Irigoyen J; Santamaría E
J Proteomics; 2016 Oct; 148():149-58. PubMed ID: 27498392
[TBL] [Abstract][Full Text] [Related]
12. Correlations between cortical and subcortical tau pathology.
Attems J; Thomas A; Jellinger K
Neuropathol Appl Neurobiol; 2012 Oct; 38(6):582-90. PubMed ID: 22115520
[TBL] [Abstract][Full Text] [Related]
13. Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis.
Irwin DJ; Grossman M; Weintraub D; Hurtig HI; Duda JE; Xie SX; Lee EB; Van Deerlin VM; Lopez OL; Kofler JK; Nelson PT; Jicha GA; Woltjer R; Quinn JF; Kaye J; Leverenz JB; Tsuang D; Longfellow K; Yearout D; Kukull W; Keene CD; Montine TJ; Zabetian CP; Trojanowski JQ
Lancet Neurol; 2017 Jan; 16(1):55-65. PubMed ID: 27979356
[TBL] [Abstract][Full Text] [Related]
14. Olfactory Bulb Amyloid-β Correlates With Brain Thal Amyloid Phase and Severity of Cognitive Impairment.
Tremblay C; Serrano GE; Intorcia AJ; Mariner MR; Sue LI; Arce RA; Atri A; Adler CH; Belden CM; Shill HA; Driver-Dunckley E; Mehta SH; Beach TG
J Neuropathol Exp Neurol; 2022 Jul; 81(8):643-649. PubMed ID: 35751438
[TBL] [Abstract][Full Text] [Related]
15. Neuropathological assessment of the olfactory bulb and tract in individuals with COVID-19.
Lengacher NA; Tomlinson JJ; Jochum AK; Franz J; Hasan Ali O; Flatz L; Jochum W; Penninger J; ; Stadelmann C; Woulfe JM; Schlossmacher MG
Acta Neuropathol Commun; 2024 May; 12(1):70. PubMed ID: 38698465
[TBL] [Abstract][Full Text] [Related]
16. Propagation of alpha-synuclein pathology from the olfactory bulb: possible role in the pathogenesis of dementia with Lewy bodies.
Cersosimo MG
Cell Tissue Res; 2018 Jul; 373(1):233-243. PubMed ID: 29196808
[TBL] [Abstract][Full Text] [Related]
17. COVID-19 and olfactory dysfunction: a looming wave of dementia?
Kay LM
J Neurophysiol; 2022 Aug; 128(2):436-444. PubMed ID: 35894511
[TBL] [Abstract][Full Text] [Related]
18. Neurodegenerative changes in the brainstem and olfactory bulb in people older than 50 years old: a descriptive study.
Oliveira FH; Rodrigues Neto E; Fonseca MK; Costa AS; Rockenbach MA; Padilha Rdos S; Fernandez LL; Hilbig A
Arq Neuropsiquiatr; 2015 Jul; 73(7):569-77. PubMed ID: 26200050
[TBL] [Abstract][Full Text] [Related]
19. Olfaction in Parkinson's disease and related disorders.
Doty RL
Neurobiol Dis; 2012 Jun; 46(3):527-52. PubMed ID: 22192366
[TBL] [Abstract][Full Text] [Related]
20. [Sense of smell, physiological ageing and neurodegenerative diseases: II. Ageing and neurodegenerative diseases].
Fusari A; Molina JA
Rev Neurol; 2009 Oct 1-15; 49(7):363-9. PubMed ID: 19774531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
